Glenmark Pharmaceuticals Ltd

NSE: GLENMARK BSE: 532296

₹2136.70

(0.58%)

Sun, 08 Mar 2026, 04:00 pm

MTF 5xInvest in Glenmark Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap603.26B

PE Ratio56.64

Dividend0.23

Health Technology

Pharmaceuticals: Major

24.5K

Glenmark Pharmaceuticals Ltd About

Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredient to regulated and semi-regulated markets.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1977

Headquarters

CEO

Glenn Saldanha

Employees

Contact

Website

http://www.glenmarkpharma.com

complianceofficer@glenmarkpharma.com

Phone

91-22-40189999

Location

B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026

Executives

Glenn Saldanha

Chairman / Executive Director / M D / Promoter

Cheryl Pinto

ED / WTD / Promoter

Anurag Mantri

ED / President / Global CFO

B E Saldanha

Non Executive Director

Sona Saira Ramasastry

Independent Non Exe. Director

Dipankar Bhattacharjee

Independent Non Exe. Director

V R Iyer

Independent Non Exe. Director

Pradeep Kumar Sinha

Independent Non Exe. Director

Harish Kuber

Company Sec. & Compli. Officer

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800